Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 21-Jun-23 10:58 AM View:  | Auberton-Herve Andre-Jacques Director | Bionik Laboratories Corp. (BNKL) | 13-Jun-23 | Conversion | 186,111 | $0.60 | $111,667.00 | 18% 1.03M to 1.22M | |
| 21-Jun-23 10:59 AM View: | Gaston-Dreyfus Remi Director 10% Owner | Bionik Laboratories Corp. (BNKL) | 13-Jun-23 | Conversion | 3,102,880 | $0.60 | $1,861,730.00 | 165% 1.88M to 4.98M | |
| 21-Jun-23 10:55 AM View: | Auberton-Herve Andre-Jacques Director | Bionik Laboratories Corp. (BNKL) | 09-Jun-23 | Purchase | 650,000 | $0.60 | $390,000.00 | 172% 379.0K to 1.03M | |
| 21-Jun-23 10:57 AM View: | Gaston-Dreyfus Remi Director 10% Owner | Bionik Laboratories Corp. (BNKL) | 09-Jun-23 | Purchase Duplicate | 180,555 | $0.60 | $108,333.00 | 11% 1.7M to 1.88M | |
| 21-Jun-23 10:57 AM View: | Matine Charles Director | Bionik Laboratories Corp. (BNKL) | 09-Jun-23 | Purchase | 180,555 | $0.60 | $108,333.00 | 683% 26.43K to 206.99K | |
| 21-Jun-22 5:47 PM View: | Gaston-Dreyfus Remi Director 10% Owner | Bionik Laboratories Corp. (BNKL) | 31-Mar-22 | Conversion | 77,887 | $9.50 | $739,926.00 | 5% 1.6M to 1.68M | |
| 13-Dec-21 4:32 PM View: | Gaston-Dreyfus Remi Director 10% Owner | Bionik Laboratories Corp. (BNKL) | 15-Jul-21 | Option Exercise | 120,759 | -- | -- | 8% 1.54M to 1.66M | |
| 21-Jun-22 5:49 PM View: | Auberton-Herve Andre-Jacques Director | Bionik Laboratories Corp. (BNKL) | 15-Jul-21 | Option Exercise | 59,378 | $3.54 | $210,201.00 | 19% 319.62K to 379.0K | |
| 31-Mar-21 3:50 PM View: | Matine Charles Director | Bionik Laboratories Corp. (BNKL) | 29-Mar-21 | Purchase | 26,430 | -- | -- | 100% 0 to 26.43K | |
| 13-Dec-21 4:31 PM View: | Gaston-Dreyfus Remi Director 10% Owner | Bionik Laboratories Corp. (BNKL) | 29-Mar-21 | Grant | 61,256 | -- | -- | 4% 1.48M to 1.54M | |
| 31-Mar-21 3:51 PM View: | Thevenon Audrey Director | Bionik Laboratories Corp. (BNKL) | 29-Mar-21 | Purchase | 26,430 | -- | -- | 100% 0 to 26.43K | |
| 31-Mar-21 3:50 PM View: | Malone Peter Gerald Director | Bionik Laboratories Corp. (BNKL) | 29-Mar-21 | Purchase | 26,430 | -- | -- | 100% 0 to 26.43K | |
| 31-Mar-21 5:34 PM View: | Martin Joseph R Director | Bionik Laboratories Corp. (BNKL) | 29-Mar-21 | Purchase | 26,430 | -- | -- | 100% 0 to 26.43K | |
| 13-Dec-21 4:30 PM View: | Gaston-Dreyfus Remi Director 10% Owner | Bionik Laboratories Corp. (BNKL) | 26-Mar-21 | Purchase | 135,560 | -- | -- | 10% 1.34M to 1.48M | |
| 01-Apr-21 12:22 PM View: | Auberton-Herve Andre-Jacques Chairman Director | Bionik Laboratories Corp. (BNKL) | 26-Mar-21 | Purchase | 95,149 | -- | -- | 42% 224.47K to 319.62K | |
| 27-Nov-19 10:31 AM View: | Gaston-Dreyfus Remi Director 10% Owner | Bionik Laboratories Corp. (BNKL) | 25-Nov-19 | Conversion | 4,997 | -- | -- | < 1% 1.28M to 1.28M | |
| 03-Oct-19 10:48 AM View: | Gaston-Dreyfus Remi Director 10% Owner | Bionik Laboratories Corp. (BNKL) | 30-Sep-19 | Conversion | 76,225 | $6.80 | $518,330.00 | 6% 1.2M to 1.28M | |
| 28-Aug-19 12:52 PM View: | Gaston-Dreyfus Remi Director 10% Owner | Bionik Laboratories Corp. (BNKL) | 26-Aug-19 | Purchase | 106,358 | $3.76 | $399,906.00 | 10% 1.1M to 1.2M | |
| 05-Apr-19 3:40 PM View: | Gaston-Dreyfus Remi Director 10% Owner | Bionik Laboratories Corp. (BNKL) | 28-Mar-19 | Conversion | 197,234 | $3.89 | $766,747.00 | 22% 897.82K to 1.1M | |
| 09-Apr-19 6:42 PM View: | Auberton-Herve Andre-Jacques Director | Bionik Laboratories Corp. (BNKL) | 28-Mar-19 | Conversion | 81,492 | $3.89 | $316,800.00 | 57% 142.98K to 224.47K | |
| 26-Jul-18 1:55 PM View: | Auberton-Herve Andre-Jacques Director | Bionik Laboratories Corp. (BNKL) | 24-Jul-18 | Conversion | 6,688,480 | $0.05 | $343,119.00 | 45% 14.76M to 21.45M | |
| 26-Jul-18 1:56 PM View: | Gaston-Dreyfus Remi Director 10% Owner | Bionik Laboratories Corp. (BNKL) | 24-Jul-18 | Conversion | 43,468,500 | $0.05 | $2,229,940.00 | 48% 91.2M to 134.67M | |
| 28-Jun-18 2:20 PM View: | Gaston-Dreyfus Remi Director 10% Owner | Bionik Laboratories Corp. (BNKL) | 13-Jun-18 | Conversion | 15,740,700 | $0.06 | $983,796.00 | 21% 75.46M to 91.2M | |
| 15-Jun-18 2:39 PM View: | Auberton-Herve Andre-Jacques Director | Bionik Laboratories Corp. (BNKL) | 13-Jun-18 | Conversion | 2,079,270 | $0.06 | $129,954.00 | 8% 27.44M to 29.52M | |
| 03-Apr-18 7:26 PM View: | Auberton-Herve Andre-Jacques Director | Bionik Laboratories Corp. (BNKL) | 31-Mar-18 | Conversion | 12,679,400 | $0.06 | $792,465.00 | 100% 12.68M to 25.36M | |
| 03-Apr-18 6:53 PM View: | Gaston-Dreyfus Remi Director 10% Owner | Bionik Laboratories Corp. (BNKL) | 31-Mar-18 | Conversion | 75,463,400 | $0.06 | $4,716,460.00 | 100% 75.46M to 150.93M | |
| 02-Mar-15 4:23 PM View: | Kibler Austin Senior Vice President Director | Bionik Laboratories Corp. (BNKL) | 26-Feb-15 | Disposition | 90,207,200 | -- | -- | (100%) 90.26M to 50.0K |
